Similar drugsTo uncover Dosage form: & nbspointment for rectal and external userectal suppositories Composition:The active component of the preparation is corpuscular components and metabolic products Esherichia coli, and hydrocortisone.Ointment: In 1 g of the ointment contains phenol-inactivated E. coli microbial cells (500 million), hydrocortisone 2.5 mg.Excipients: lanolin, petrolatum, phenol (preservative).Suppositories: In 1 suppository contain phenol-inactivated E. coli microbial cells (1000 million), hydrocortisone 5 mg. Excipients: acetylcysteine, α-tocopherol, disodium edetate, macrogol-glycerol hydroxystearate, solid fat, phenol (preservative). Description:Ointment - homogeneous from yellowish to light brown color with a characteristic smell of phenol.Suppositories - torpedo-shaped suppositories from white to yellowish color with a characteristic smell of phenol. Pharmacotherapeutic group:Antihemorrhoids for topical use, combination. ATX: & nbspPreparations for the treatment of hemorrhoids and anal fissures in combination Pharmacodynamics:Cell wall antigens and metabolic products of Escherichia coli in contact with the rectal mucosa and the skin of the anogenital region increase local tissue resistance to pathogenic microflora.The preparation stimulates the immune T-system, the phagocytic activity of leukocytes and cells of the reticuloendothelial system, nonspecific immunity factors, exudation decreases in inflammation, normalises the tone and permeability of blood vessels, stimulating the regeneration of damaged tissues.Hydrocortisone with local application has anti-inflammatory and antiallergic effect. When applied to the affected surface, it reduces swelling, flushing, itching. Indications:Ointment appoint an adult with the following diseases:- persistent course of hemorrhoids;- perianal dermatitis;- anal itching, especially resistant to other medicines;anopapillite;anal fissure.Suppositories appoint an adult with the following diseases:- persistent course of hemorrhoids;- anal itching, especially resistant to other medicines;anopapillite;anal fissure. Contraindications:Hypersensitivity to hydrocortisone or other components of the drug.Bacterial diseases in the field of treatment (for example, tuberculosis, syphilis, gonorrhea).Fungal diseases in the field of treatment. Pregnancy and lactation:There is no indication that hydrocortisone from the ointment or suppository "Posterizan Forte" falls into the placenta or into the mother's milk. To date, no evidence has been found that indicates a damaging effect of the drug on the fetus.However, ointment or suppositories "Posterizan Forte", like all medicines, should be used during pregnancy and lactation only with strict medical supervision. Dosing and Administration:Ointment apply a thin layer on the affected skin and mucous membrane in the morning and evening, and after each defecation. For a deeper introduction of the ointment into the anal canal, you can use a screw-on applicator attached to the kit.Suppositories rectal apply in the morning and in the evening, and also after each defecation.It is possible to combine the use of ointments and suppositories.The course of treatment lasts 2-3 weeks. Side effects:As a preservative in the preparation is used phenol, so allergic reactions are possible in patients with increased sensitivity to this component. Interaction:With the simultaneous use of ointments or suppositories "Posterizan forte" and other drugs with glucocorticoids (tablets, drops or injections), actions or side effects may increase.Please note that these guidelines may also apply to medicines that have recently been used. Form release / dosage:Ointment.Suppositories rectal. Packaging:Ointment of 25 g in an aluminum tube, in a pack of cardboard.Suppositories rectal for 5 pieces in a blister, 2 blisters (10 suppositories) in a pack of cardboard. Storage conditions:In dry, sheltered from light and out of the reach of children,temperature from 0 ° C to 25 ° C. Shelf life:Ointment - 3 years.Suppositories - 2 years.Do not use after the expiry date printed on the package! Terms of leave from pharmacies:Without recipe Registration number:П N014065 / 01 Date of registration:14.05.2010 The owner of the registration certificate:Dr. Kade Pharmaceutical Factory GmbHDr. Kade Pharmaceutical Factory GmbH Germany Manufacturer: & nbspDr. KADE Pharmazeutische Fabrik, GmbH Germany Representation: & nbspNPK Katren AONPK Katren AORussia Information update date: & nbsp2016-02-01 Illustrated instructions × Illustrated instructions Instructions